Cancer care during the COVID-19 pandemic: a perspective from Saudi Arabia.

Clicks: 376
ID: 113446
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #3 of 4 articles by views in ecancermedicalscience

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The coronavirus disease 2019 (COVID-19) pandemic continues to disrupt many healthcare settings worldwide including cancer care. COVID-19 has been associated with worse outcomes amongst cancer patients. Saudi Arabia has experienced several Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks that affected the continuity of cancer care. In this paper, we describe how Saudi Arabia responded to COVID-19, how cancer care was re-restructured during this pandemic and how the recent MERS-CoV experience may have improved the Saudi response to COVID-19.
Reference Key
alessy2020cancerecancermedicalscience Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Alessy, Saleh A;Davies, Elizabeth A;Jazieh, Abdul-Rahman;
Journal ecancermedicalscience
Year 2020
DOI
10.3332/ecancer.2020.1076
URL
Keywords
Cancer care saudi arabia covid-19

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.